Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Suzhou Langke Biotechnology is a Chinese life sciences company focused on the research, development, and manufacturing of high-quality molecular biology reagents and enzymes. The company provides a comprehensive portfolio of products, including DNA polymerases, reverse transcriptases, and specialized kits for PCR, qPCR, and Next-Generation Sequencing (NGS) library preparation. Headquartered in the Suzhou Industrial Park, Suzhou Langke serves a global clientele of research laboratories, diagnostic developers, and biotechnology enterprises by providing critical raw materials for genetic analysis and molecular diagnostics. Their expertise lies in protein engineering and large-scale fermentation, ensuring high purity and activity of their enzymatic products. The company also offers customized reagent development and OEM services to support the specific needs of the IVD and biotechnology industries.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Suzhou Langke Biotechnology.